{"data":{"mode":"full","deterministic":false,"llmCalls":1,"decidedBy":{"code":0,"llm":2,"llm+code":2,"none":0},"degraded":null,"focus":"Does postmenopausal estrogen plus progestin therapy reduce coronary heart disease risk?","summary":{"CONTRADICTS":1,"CONSISTENT":0,"DIFFERENT_POPULATIONS_OR_MEASURES":2,"INSUFFICIENT_INFO":1,"pairsTested":1},"papers":[{"index":0,"input":"10.1056/NEJM199608153350701","idKind":"doi","resolved":true,"title":"Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.","doi":"10.1056/nejm199608153350701","year":1996,"venue":"The New England journal of medicine","url":"https://doi.org/10.1056/nejm199608153350701","text":{"level":"abstract","origin":"abstract","chars":1663},"integrity":{"status":"corrected","notices":[{"type":"has erratum (Europe PMC: Erratum in)","doi":null,"date":null,"source":"europepmc"}],"sourcesChecked":["europepmc","crossref","europepmc:commentCorrectionList"]},"replicationSignals":{"scite":{"supporting":6,"contradicting":4,"mentioning":330},"citingSentencesScanned":0,"failedReplications":[]},"sampleSize":{"max":59337,"hints":[{"n":59337,"text":"59,337 women"}]},"preregistration":{"present":null,"quote":null,"cue":null},"funding":{"present":null,"quote":null,"cue":null},"conflictOfInterest":{"present":null,"quote":null,"cue":null},"claimsExtracted":4,"trust":{"score":62,"band":"moderate","components":[{"name":"retraction","points":0,"assessed":true,"detail":"integrity status corrected"},{"name":"expression_of_concern","points":0,"assessed":true,"detail":"none found"},{"name":"correction","points":10,"assessed":true,"detail":"correction or erratum on record"},{"name":"failed_replications","points":0,"assessed":true,"detail":"0 plain failed-replication statement(s) in citing sentences"},{"name":"scite_contradicting_share","points":8,"assessed":true,"detail":"4 contradicting of 10 supporting + contradicting statements"},{"name":"sample_size","points":0,"assessed":true,"detail":"largest stated n = 59337"},{"name":"preregistration","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"funding_statement","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"conflict_of_interest_statement","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"contradicted_by_other_papers","points":20,"assessed":true,"detail":"1 contradicted of 1 tested pair(s)"}],"contradiction":{"contradicted":1,"tested":1,"rate":1}}},{"index":1,"input":"10.1001/jama.288.3.321","idKind":"doi","resolved":true,"title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.","doi":"10.1001/jama.288.3.321","year":2002,"venue":"JAMA","url":"https://doi.org/10.1001/jama.288.3.321","text":{"level":"abstract","origin":"abstract","chars":3391},"integrity":{"status":"none","notices":[],"sourcesChecked":["crossref","europepmc","europepmc:commentCorrectionList"]},"replicationSignals":{"scite":{"supporting":32,"contradicting":4,"mentioning":1774},"citingSentencesScanned":0,"failedReplications":[]},"sampleSize":{"max":16608,"hints":[{"n":8506,"text":"n = 8506"},{"n":8102,"text":"n = 8102"},{"n":16608,"text":"16608 postmenopausal women"}]},"preregistration":{"present":null,"quote":null,"cue":null},"funding":{"present":null,"quote":null,"cue":null},"conflictOfInterest":{"present":null,"quote":null,"cue":null},"claimsExtracted":13,"trust":{"score":78,"band":"moderate","components":[{"name":"retraction","points":0,"assessed":true,"detail":"integrity status none"},{"name":"expression_of_concern","points":0,"assessed":true,"detail":"none found"},{"name":"correction","points":0,"assessed":true,"detail":"none found"},{"name":"failed_replications","points":0,"assessed":true,"detail":"0 plain failed-replication statement(s) in citing sentences"},{"name":"scite_contradicting_share","points":2.22,"assessed":true,"detail":"4 contradicting of 36 supporting + contradicting statements"},{"name":"sample_size","points":0,"assessed":true,"detail":"largest stated n = 16608"},{"name":"preregistration","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"funding_statement","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"conflict_of_interest_statement","points":0,"assessed":false,"detail":"not assessable from an abstract"},{"name":"contradicted_by_other_papers","points":20,"assessed":true,"detail":"1 contradicted of 1 tested pair(s)"}],"contradiction":{"contradicted":1,"tested":1,"rate":1}}}],"claims":[{"id":"p0c1","paper":0,"section":"abstract","quote":"multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78","span":{"start":1028,"end":1115},"measure":"RR","value":0.39,"ci":{"lo":0.19,"hi":0.78,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":{"word":"decrease","kind":"down"},"outcomePhrase":"coronary disease heart"},{"id":"p0c2","paper":0,"section":"abstract","quote":"or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83)","span":{"start":1117,"end":1202},"measure":"RR","value":0.6,"ci":{"lo":0.43,"hi":0.83,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":{"word":"decrease","kind":"down"},"outcomePhrase":"coronary disease heart"},{"id":"p0c3","paper":0,"section":"abstract","quote":"multivariate adjusted relative risk, 1.09; 95 percent confidence interval, 0.66 to 1.80","span":{"start":1356,"end":1443},"measure":"RR","value":1.09,"ci":{"lo":0.66,"hi":1.8,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":{"word":"no significant","kind":"null"},"outcomePhrase":"stroke"},{"id":"p0c4","paper":0,"section":"abstract","quote":"or estrogen alone (relative risk, 1.27; 95 percent confidence interval, 0.95 to 1.69)","span":{"start":1445,"end":1530},"measure":"RR","value":1.27,"ci":{"lo":0.95,"hi":1.69,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":{"word":"no significant","kind":"null"},"outcomePhrase":"stroke"},{"id":"p1c1","paper":1,"section":"abstract","quote":"CHD, 1.29 (1.02-1.63)","span":{"start":1837,"end":1858},"measure":"HR","value":1.29,"ci":{"lo":1.02,"hi":1.63,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"coronary disease heart"},{"id":"p1c2","paper":1,"section":"abstract","quote":"breast cancer, 1.26 (1.00-1.59)","span":{"start":1875,"end":1906},"measure":"HR","value":1.26,"ci":{"lo":1,"hi":1.59,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"breast cancer"},{"id":"p1c3","paper":1,"section":"abstract","quote":"stroke, 1.41 (1.07-1.85)","span":{"start":1923,"end":1947},"measure":"HR","value":1.41,"ci":{"lo":1.07,"hi":1.85,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"stroke"},{"id":"p1c4","paper":1,"section":"abstract","quote":"PE, 2.13 (1.39-3.25)","span":{"start":1964,"end":1984},"measure":"HR","value":2.13,"ci":{"lo":1.39,"hi":3.25,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"embolism pulmonary"},{"id":"p1c5","paper":1,"section":"abstract","quote":"colorectal cancer, 0.63 (0.43-0.92)","span":{"start":2001,"end":2036},"measure":"HR","value":0.63,"ci":{"lo":0.43,"hi":0.92,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"cancer colorectal"},{"id":"p1c6","paper":1,"section":"abstract","quote":"endometrial cancer, 0.83 (0.47-1.47)","span":{"start":2053,"end":2089},"measure":"HR","value":0.83,"ci":{"lo":0.47,"hi":1.47,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"cancer endometrial"},{"id":"p1c7","paper":1,"section":"abstract","quote":"hip fracture, 0.66 (0.45-0.98)","span":{"start":2105,"end":2135},"measure":"HR","value":0.66,"ci":{"lo":0.45,"hi":0.98,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"fracture hip"},{"id":"p1c8","paper":1,"section":"abstract","quote":"death due to other causes, 0.92 (0.74-1.14)","span":{"start":2156,"end":2199},"measure":"HR","value":0.92,"ci":{"lo":0.74,"hi":1.14,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"cause death due"},{"id":"p1c9","paper":1,"section":"abstract","quote":"Corresponding HRs (nominal 95% CIs) for composite outcomes were 1.22 (1.09-1.36) for total cardiovascular disease","span":{"start":2216,"end":2329},"measure":"HR","value":1.22,"ci":{"lo":1.09,"hi":1.36,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"cardiovascular disease"},{"id":"p1c10","paper":1,"section":"abstract","quote":"1.03 (0.90-1.17) for total cancer","span":{"start":2361,"end":2394},"measure":"HR","value":1.03,"ci":{"lo":0.9,"hi":1.17,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"cancer"},{"id":"p1c11","paper":1,"section":"abstract","quote":"0.76 (0.69-0.85) for combined fractures","span":{"start":2396,"end":2435},"measure":"HR","value":0.76,"ci":{"lo":0.69,"hi":0.85,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"fracture"},{"id":"p1c12","paper":1,"section":"abstract","quote":"0.98 (0.82-1.18) for total mortality","span":{"start":2437,"end":2473},"measure":"HR","value":0.98,"ci":{"lo":0.82,"hi":1.18,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"death"},{"id":"p1c13","paper":1,"section":"abstract","quote":"1.15 (1.03-1.28) for the global index.","span":{"start":2479,"end":2517},"measure":"HR","value":1.15,"ci":{"lo":1.03,"hi":1.28,"level":95,"levelAssumed":false},"p":null,"unit":null,"n":null,"direction":null,"outcomePhrase":"global index"}],"pairs":[{"id":"pair-1","a":{"claimId":"p0c1","paper":0,"quote":"multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78","sentence":"Results We observed a marked decrease in the risk of major coronary heart disease among women who took estrogen with progestin (multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78) or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83), as compared with women who did not use hormones [corrected]."},"b":{"claimId":"p1c1","paper":1,"quote":"CHD, 1.29 (1.02-1.63)","sentence":"Estimated hazard ratios (HRs) (nominal 95% confidence intervals [CIs]) were as follows: CHD, 1.29 (1.02-1.63) with 286 cases; breast cancer, 1.26 (1.00-1.59) with 290 cases; stroke, 1.41 (1.07-1.85) with 212 cases; PE, 2.13 (1.39-3.25) with 101 cases; colorectal cancer, 0.63 (0.43-0.92) with 112 cases; endometrial cancer, 0.83 (0.47-1.47) with 47 cases; hip fracture, 0.66 (0.45-0.98) with 106 cases; and death due to other causes, 0.92 (0.74-1.14) with 331 cases."},"classification":"CONTRADICTS","contradictionKind":"opposite_direction","decidedBy":"llm+code","scope":"verified model judgment; statistics in code","reasons":["direction","ci_overlap","difference"],"notes":["RR compared with HR on the log scale"],"tests":[{"name":"direction","applicable":true,"fired":true,"detail":{"signA":-1,"signB":1,"significantA":true,"significantB":true}},{"name":"ci_overlap","applicable":true,"fired":true,"detail":{"overlap":false,"ciA":"-1.6607..-0.2485","ciB":"0.0198..0.4886"}},{"name":"difference","applicable":true,"fired":true,"detail":{"d":-1.1963,"se":0.3796,"z":-3.1513,"p":0.0016,"seSourceA":"ci","seSourceB":"ci"}},{"name":"significant_vs_null","applicable":false,"fired":false,"detail":{"power":null,"adequatePower":null,"significantEstimateInsideNullCi":null,"differenceSignificant":true,"nullSeSource":null}}],"candidateScore":1.5,"exactOutcome":true,"judgment":{"id":"pair-1","sameOutcome":true,"sameMeasure":true,"comparablePopulations":true,"sameQuantity":true,"verified":true,"populationStated":{"a":true,"b":true},"quotes":{"populationA":"women who took estrogen with progestin","populationB":"conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, in 1 tablet (n = 8506) or placebo (n = 8102)","outcomeA":"major coronary heart disease","outcomeB":"CHD","measureA":"multivariate adjusted relative risk","measureB":"Estimated hazard ratios"},"failedQuotes":[],"rationale":"Both report a ratio for CHD (MI or coronary death) with combined estrogen plus progestin versus no hormones or placebo, so they are directly comparable despite the observational versus randomized designs."}},{"id":"pair-2","a":{"claimId":"p0c2","paper":0,"quote":"or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83)","sentence":"Results We observed a marked decrease in the risk of major coronary heart disease among women who took estrogen with progestin (multivariate adjusted relative risk, 0.39; 95 percent confidence interval, 0.19 to 0.78) or estrogen alone (relative risk, 0.60; 95 percent confidence interval, 0.43 to 0.83), as compared with women who did not use hormones [corrected]."},"b":{"claimId":"p1c1","paper":1,"quote":"CHD, 1.29 (1.02-1.63)","sentence":"Estimated hazard ratios (HRs) (nominal 95% confidence intervals [CIs]) were as follows: CHD, 1.29 (1.02-1.63) with 286 cases; breast cancer, 1.26 (1.00-1.59) with 290 cases; stroke, 1.41 (1.07-1.85) with 212 cases; PE, 2.13 (1.39-3.25) with 101 cases; colorectal cancer, 0.63 (0.43-0.92) with 112 cases; endometrial cancer, 0.83 (0.47-1.47) with 47 cases; hip fracture, 0.66 (0.45-0.98) with 106 cases; and death due to other causes, 0.92 (0.74-1.14) with 331 cases."},"classification":"DIFFERENT_POPULATIONS_OR_MEASURES","contradictionKind":null,"decidedBy":"llm","scope":"verified model judgment","reasons":["model: not the same quantity (population or intervention): Paper A's claim concerns estrogen alone whereas paper B tested estrogen plus progestin, so the interventions differ."],"notes":[],"tests":[],"candidateScore":1.5,"exactOutcome":true,"judgment":{"id":"pair-2","sameOutcome":true,"sameMeasure":true,"comparablePopulations":false,"sameQuantity":false,"verified":true,"populationStated":{"a":true,"b":true},"quotes":{"populationA":"estrogen alone","populationB":"conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, in 1 tablet (n = 8506) or placebo (n = 8102)","outcomeA":"major coronary heart disease","outcomeB":"CHD","measureA":"relative risk","measureB":"Estimated hazard ratios"},"failedQuotes":[],"rationale":"Paper A's claim concerns estrogen alone whereas paper B tested estrogen plus progestin, so the interventions differ."}},{"id":"pair-3","a":{"claimId":"p0c4","paper":0,"quote":"or estrogen alone (relative risk, 1.27; 95 percent confidence interval, 0.95 to 1.69)","sentence":"However, there was no significant association between stroke and use of combined hormones (multivariate adjusted relative risk, 1.09; 95 percent confidence interval, 0.66 to 1.80) or estrogen alone (relative risk, 1.27; 95 percent confidence interval, 0.95 to 1.69)."},"b":{"claimId":"p1c3","paper":1,"quote":"stroke, 1.41 (1.07-1.85)","sentence":"Estimated hazard ratios (HRs) (nominal 95% confidence intervals [CIs]) were as follows: CHD, 1.29 (1.02-1.63) with 286 cases; breast cancer, 1.26 (1.00-1.59) with 290 cases; stroke, 1.41 (1.07-1.85) with 212 cases; PE, 2.13 (1.39-3.25) with 101 cases; colorectal cancer, 0.63 (0.43-0.92) with 112 cases; endometrial cancer, 0.83 (0.47-1.47) with 47 cases; hip fracture, 0.66 (0.45-0.98) with 106 cases; and death due to other causes, 0.92 (0.74-1.14) with 331 cases."},"classification":"DIFFERENT_POPULATIONS_OR_MEASURES","contradictionKind":null,"decidedBy":"llm","scope":"verified model judgment","reasons":["model: not the same quantity (population or intervention): Stroke ratios are comparable in kind, but paper A's claim is for estrogen alone while paper B tested estrogen plus progestin."],"notes":[],"tests":[],"candidateScore":1.25,"exactOutcome":true,"judgment":{"id":"pair-3","sameOutcome":true,"sameMeasure":true,"comparablePopulations":false,"sameQuantity":false,"verified":true,"populationStated":{"a":true,"b":true},"quotes":{"populationA":"estrogen alone","populationB":"conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, in 1 tablet (n = 8506) or placebo (n = 8102)","outcomeA":"stroke","outcomeB":"stroke","measureA":"relative risk","measureB":"Estimated hazard ratios"},"failedQuotes":[],"rationale":"Stroke ratios are comparable in kind, but paper A's claim is for estrogen alone while paper B tested estrogen plus progestin."}},{"id":"pair-4","a":{"claimId":"p0c3","paper":0,"quote":"multivariate adjusted relative risk, 1.09; 95 percent confidence interval, 0.66 to 1.80","sentence":"However, there was no significant association between stroke and use of combined hormones (multivariate adjusted relative risk, 1.09; 95 percent confidence interval, 0.66 to 1.80) or estrogen alone (relative risk, 1.27; 95 percent confidence interval, 0.95 to 1.69)."},"b":{"claimId":"p1c3","paper":1,"quote":"stroke, 1.41 (1.07-1.85)","sentence":"Estimated hazard ratios (HRs) (nominal 95% confidence intervals [CIs]) were as follows: CHD, 1.29 (1.02-1.63) with 286 cases; breast cancer, 1.26 (1.00-1.59) with 290 cases; stroke, 1.41 (1.07-1.85) with 212 cases; PE, 2.13 (1.39-3.25) with 101 cases; colorectal cancer, 0.63 (0.43-0.92) with 112 cases; endometrial cancer, 0.83 (0.47-1.47) with 47 cases; hip fracture, 0.66 (0.45-0.98) with 106 cases; and death due to other causes, 0.92 (0.74-1.14) with 331 cases."},"classification":"INSUFFICIENT_INFO","contradictionKind":null,"decidedBy":"llm+code","scope":"verified model judgment; statistics in code","reasons":["one result is null with power 0.27 < 0.8 to detect the other's estimate"],"notes":["RR compared with HR on the log scale"],"tests":[{"name":"direction","applicable":false,"fired":false,"detail":{"signA":1,"signB":1,"significantA":false,"significantB":true}},{"name":"ci_overlap","applicable":true,"fired":false,"detail":{"overlap":true,"ciA":"-0.4155..0.5878","ciB":"0.0677..0.6152"}},{"name":"difference","applicable":true,"fired":false,"detail":{"d":-0.2574,"se":0.2916,"z":-0.8828,"p":0.3773,"seSourceA":"ci","seSourceB":"ci"}},{"name":"significant_vs_null","applicable":true,"fired":false,"detail":{"power":0.2689,"adequatePower":false,"significantEstimateInsideNullCi":true,"differenceSignificant":false,"nullSeSource":"ci"}}],"candidateScore":1,"exactOutcome":true,"judgment":{"id":"pair-4","sameOutcome":true,"sameMeasure":true,"comparablePopulations":true,"sameQuantity":true,"verified":true,"populationStated":{"a":true,"b":true},"quotes":{"populationA":"women who took estrogen with progestin","populationB":"conjugated equine estrogens, 0.625 mg/d, plus medroxyprogesterone acetate, 2.5 mg/d, in 1 tablet (n = 8506) or placebo (n = 8102)","outcomeA":"stroke","outcomeB":"stroke","measureA":"multivariate adjusted relative risk","measureB":"Estimated hazard ratios"},"failedQuotes":[],"rationale":"Both give ratio measures for stroke with combined estrogen plus progestin versus no hormones or placebo in postmenopausal women."}}],"trustMethod":{"formula":"score = 100, then subtract: retracted -> 0; expression of concern 40; correction 10; failed replications found in citing-sentence lexicon 10 each (cap 20); scite contradicting share of (supporting + contradicting) x 20 when at least 5 classified statements; largest stated sample size below 50: 10, not stated in full text: 5; no preregistration cue in full text: 5; no funding statement in full text: 3; no conflict-of-interest statement in full text: 3; 40 x contradicted / (tested + 1) over this request's CONTRADICTS and CONSISTENT pairs involving the paper. Clamped to 0-100. Missing items that cannot be assessed from an abstract are not penalized.","weights":{"base":100,"expressionOfConcern":40,"corrected":10,"failedReplicationEach":10,"failedReplicationCap":20,"sciteMinClassified":5,"sciteMax":20,"smallSampleN":50,"smallSample":10,"sampleUnknown":5,"noPreregistration":5,"noFunding":3,"noConflictStatement":3,"contradictionMax":40,"bands":{"high":80,"moderate":60,"low":40}},"excluded":["author h-index or citation counts","journal impact factor or venue rank","institution rank","author fame"],"note":"Excluded on purpose: these measure prestige, not accuracy, and are not predictive of whether a finding is correct."},"coverage":{"papersRequested":2,"papersResolved":2,"papersWithFullText":0,"claimsExtracted":17,"candidatePairsFound":4,"candidatePairsTruncated":0,"pairCap":24,"maxUpstreamCalls":20,"concurrency":6,"elapsedMs":17383,"failures":["paper 0: Semantic Scholar rate limit reached; retry later","paper 1: Semantic Scholar rate limit reached; retry later"]},"caveats":["CONTRADICTS means the reported estimates conflict statistically for claims judged to measure the same quantity; it does not say which paper is right.","Claims come from abstracts and results text; tables and figures are not read.","Funding, conflict-of-interest and preregistration are reported as not assessable when only an abstract was available.","Author-prestige metrics are excluded from trust scores on purpose."]},"_provenance":{"version":"writerslogic-provenance/1","issuer":"did:web:agents.writerslogic.com","verify":{"endpoint":"POST /api/v1/verify-provenance","did":"did:web:agents.writerslogic.com"},"manifest":{"format":"application/json","instance_id":"xmp:iid:69115128-0d67-43c3-b641-8a6af153f340","claim_generator_info":[{"name":"WritersLogic x402 Agent Hub","version":"2.0.0"}],"title":"Paper Contradiction Finder","assertions":[{"label":"c2pa.actions.v2","data":{"actions":[{"action":"c2pa.created","when":"2026-11-04T20:34:01.452Z","softwareAgent":{"name":"writerslogic-agent-hub/paperContradictions","version":"2.0.0"},"digitalSourceType":"http://cv.iptc.org/newscodes/digitalsourcetype/trainedAlgorithmicMedia","parameters":{"endpoint":"POST /api/v1/find-contradictions","inputDigest":{"alg":"sha256","hash":"9fe800f5c93a589c388d8a55770ef5cdfb2ce5bb30b3c9550eab31de337a2324","canonicalization":"JCS"}}}]}},{"label":"c2pa.hash.data","data":{"alg":"sha256","hash":"02a51c35515b03a0005f54fbcdfbde05fb8b163bdf6f973291bd5e4c45c9a6f7","name":"jcs-canonical-json(data)"}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.openalex.org/works/doi%3A10.1001%2Fjama.288.3.321?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.openalex.org/works/doi%3A10.1001%2Fjama.288.3.321?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","date":"2026-11-04T20:33:44.361Z"},"hash":{"alg":"sha256","hash":"024e512e36aeb5f55e99b7d8fff94e277e97f688fe2ecd197852d342e92e1274","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.openalex.org/works/doi%3A10.1056%2Fnejm199608153350701?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.openalex.org/works/doi%3A10.1056%2Fnejm199608153350701?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","date":"2026-11-04T20:33:44.362Z"},"hash":{"alg":"sha256","hash":"7fcf2abb64d6d292a2133ed52a0cdc3d983fecb08d4b3fa6760b821f1020c41a","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1001%2Fjama.288.3.321%22%29&format=json&resultType=core&pageSize=3","format":"application/json","relationship":"inputTo","dc":{"source":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1001%2Fjama.288.3.321%22%29&format=json&resultType=core&pageSize=3","date":"2026-11-04T20:33:45.038Z"},"hash":{"alg":"sha256","hash":"ccbc23d5f9869ee46129665795e7e8b7971f441c749975c2b1650e6e4716cf2c","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1056%2Fnejm199608153350701%22%29&format=json&resultType=core&pageSize=3","format":"application/json","relationship":"inputTo","dc":{"source":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1056%2Fnejm199608153350701%22%29&format=json&resultType=core&pageSize=3","date":"2026-11-04T20:33:45.087Z"},"hash":{"alg":"sha256","hash":"7e7aee176da449416710bfc34f167753d9f64ac96cc0fa9155984bba2f5f60a8","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1056%2Fnejm199608153350701?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1056%2Fnejm199608153350701?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","date":"2026-11-04T20:33:46.562Z"},"hash":{"alg":"sha256","hash":"65ab993d12c5c2cc9b68e6da2bb79b326930283e520363ffcdc145f88cd5a148","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1001%2Fjama.288.3.321?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1001%2Fjama.288.3.321?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","date":"2026-11-04T20:33:46.618Z"},"hash":{"alg":"sha256","hash":"65ab993d12c5c2cc9b68e6da2bb79b326930283e520363ffcdc145f88cd5a148","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.scite.ai/tallies/10.1056/nejm199608153350701","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.scite.ai/tallies/10.1056/nejm199608153350701","date":"2026-11-04T20:33:46.707Z"},"hash":{"alg":"sha256","hash":"4c88401885469c8ded7f95244ba4751fa805479df9ad184cfc59f7976f740fb7","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.openalex.org/works/doi:10.1056%2Fnejm199608153350701?select=id%2Cis_retracted&api_key=REDACTED","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.openalex.org/works/doi:10.1056%2Fnejm199608153350701?select=id%2Cis_retracted&api_key=REDACTED","date":"2026-11-04T20:33:46.758Z"},"hash":{"alg":"sha256","hash":"376dad24144029da7c983e13f831fe3ac7408405edfacb32208a11870c45b82c","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A8672166+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","format":"application/json","relationship":"inputTo","dc":{"source":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A8672166+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","date":"2026-11-04T20:33:46.797Z"},"hash":{"alg":"sha256","hash":"842e38642e89a47256dd21040f444403a562e84699688a9c998a66cb196f74f7","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.crossref.org/works/10.1056%2Fnejm199608153350701","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.crossref.org/works/10.1056%2Fnejm199608153350701","date":"2026-11-04T20:33:46.876Z"},"hash":{"alg":"sha256","hash":"e2fae5610c6f124ea3b9b07beadf4d05d01b9264c76e2aa04c486d83926694b3","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.scite.ai/tallies/10.1001/jama.288.3.321","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.scite.ai/tallies/10.1001/jama.288.3.321","date":"2026-11-04T20:33:46.926Z"},"hash":{"alg":"sha256","hash":"f242786e1415b9635e72e62dd0f3c4a445c2f03299830d1d10ed5ff3a5da634f","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.crossref.org/works/10.1001%2Fjama.288.3.321","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.crossref.org/works/10.1001%2Fjama.288.3.321","date":"2026-11-04T20:33:46.969Z"},"hash":{"alg":"sha256","hash":"2e7be6d2bed3e373fc40b499873b21586c800325d76a5ae85c9c17eb7d3a9a35","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://api.openalex.org/works/doi:10.1001%2Fjama.288.3.321?select=id%2Cis_retracted&api_key=REDACTED","format":"application/json","relationship":"inputTo","dc":{"source":"https://api.openalex.org/works/doi:10.1001%2Fjama.288.3.321?select=id%2Cis_retracted&api_key=REDACTED","date":"2026-11-04T20:33:47.000Z"},"hash":{"alg":"sha256","hash":"8a2eb2f16b11a4a440574b8e7a9241303cabe8351ad1aa3cf4981e6ea5bc082a","basis":"body"}}},{"label":"c2pa.ingredient.v3","data":{"title":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A12117397+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","format":"application/json","relationship":"inputTo","dc":{"source":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A12117397+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","date":"2026-11-04T20:33:47.045Z"},"hash":{"alg":"sha256","hash":"e3c22c53fb8a6bf9f9f7e26dcc5c1fc239672a24ea0e9f4d819e5a95d20d8e4c","basis":"body"}}}]},"credential":{"@context":["https://www.w3.org/ns/credentials/v2"],"id":"urn:uuid:cc89df6a-5169-4e49-aee9-7b79683dd58f","type":["VerifiableCredential","AgentOutputCredential"],"issuer":"did:web:agents.writerslogic.com","validFrom":"2026-11-04T20:34:01.452Z","credentialSubject":{"id":"urn:sha256:02a51c35515b03a0005f54fbcdfbde05fb8b163bdf6f973291bd5e4c45c9a6f7","agent":"paperContradictions","endpoint":"POST /api/v1/find-contradictions","outputDigest":{"alg":"sha256","value":"02a51c35515b03a0005f54fbcdfbde05fb8b163bdf6f973291bd5e4c45c9a6f7","canonicalization":"JCS"},"inputDigest":{"alg":"sha256","value":"9fe800f5c93a589c388d8a55770ef5cdfb2ce5bb30b3c9550eab31de337a2324","canonicalization":"JCS"},"manifestDigest":{"alg":"sha256","value":"f3e89aefb47fcf991b6c5ecd3be9ffb05cb4b4ca79fb5a7c9e3c74838512cf0c","canonicalization":"JCS"},"ingredients":[{"url":"https://api.openalex.org/works/doi%3A10.1001%2Fjama.288.3.321?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","sha256":"024e512e36aeb5f55e99b7d8fff94e277e97f688fe2ecd197852d342e92e1274"},{"url":"https://api.openalex.org/works/doi%3A10.1056%2Fnejm199608153350701?select=id%2Cdoi%2Cdisplay_name%2Cpublication_date%2Clanguage%2Cabstract_inverted_index%2Ccited_by_count%2Cauthorships%2Cprimary_location&api_key=REDACTED","sha256":"7fcf2abb64d6d292a2133ed52a0cdc3d983fecb08d4b3fa6760b821f1020c41a"},{"url":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1001%2Fjama.288.3.321%22%29&format=json&resultType=core&pageSize=3","sha256":"ccbc23d5f9869ee46129665795e7e8b7971f441c749975c2b1650e6e4716cf2c"},{"url":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28DOI%3A%2210.1056%2Fnejm199608153350701%22%29&format=json&resultType=core&pageSize=3","sha256":"7e7aee176da449416710bfc34f167753d9f64ac96cc0fa9155984bba2f5f60a8"},{"url":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1056%2Fnejm199608153350701?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","sha256":"65ab993d12c5c2cc9b68e6da2bb79b326930283e520363ffcdc145f88cd5a148"},{"url":"https://api.semanticscholar.org/graph/v1/paper/DOI%3A10.1001%2Fjama.288.3.321?fields=paperId,externalIds,title,abstract,year,publicationDate,venue,citationCount,authors","sha256":"65ab993d12c5c2cc9b68e6da2bb79b326930283e520363ffcdc145f88cd5a148"},{"url":"https://api.scite.ai/tallies/10.1056/nejm199608153350701","sha256":"4c88401885469c8ded7f95244ba4751fa805479df9ad184cfc59f7976f740fb7"},{"url":"https://api.openalex.org/works/doi:10.1056%2Fnejm199608153350701?select=id%2Cis_retracted&api_key=REDACTED","sha256":"376dad24144029da7c983e13f831fe3ac7408405edfacb32208a11870c45b82c"},{"url":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A8672166+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","sha256":"842e38642e89a47256dd21040f444403a562e84699688a9c998a66cb196f74f7"},{"url":"https://api.crossref.org/works/10.1056%2Fnejm199608153350701","sha256":"e2fae5610c6f124ea3b9b07beadf4d05d01b9264c76e2aa04c486d83926694b3"},{"url":"https://api.scite.ai/tallies/10.1001/jama.288.3.321","sha256":"f242786e1415b9635e72e62dd0f3c4a445c2f03299830d1d10ed5ff3a5da634f"},{"url":"https://api.crossref.org/works/10.1001%2Fjama.288.3.321","sha256":"2e7be6d2bed3e373fc40b499873b21586c800325d76a5ae85c9c17eb7d3a9a35"},{"url":"https://api.openalex.org/works/doi:10.1001%2Fjama.288.3.321?select=id%2Cis_retracted&api_key=REDACTED","sha256":"8a2eb2f16b11a4a440574b8e7a9241303cabe8351ad1aa3cf4981e6ea5bc082a"},{"url":"https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID%3A12117397+AND+SRC%3AMED&format=json&resultType=core&pageSize=1","sha256":"e3c22c53fb8a6bf9f9f7e26dcc5c1fc239672a24ea0e9f4d819e5a95d20d8e4c"}],"payment":{"scheme":"api-key","network":"eip155:8453","payer":"sample"}},"proof":{"type":"DataIntegrityProof","cryptosuite":"eddsa-jcs-2022","created":"2026-11-04T20:34:01.452Z","verificationMethod":"did:web:agents.writerslogic.com#key-1","proofPurpose":"assertionMethod","proofValue":"z33kNry8xeBKcnvs8AVDYtERC1YRPV7g31z5Z8JXHv8bb3yd8xf5fLMik6hT85WxtQe4HtkdcRzCVeZdR4XMgHgPT"}},"ethSignature":{"type":"EIP-191","signer":"did:pkh:eip155:8453:0x3DBd42560cA7a7E448A2c7DfC9E785526189411f","address":"0x3DBd42560cA7a7E448A2c7DfC9E785526189411f","message":"writerslogic-provenance:cd068b95a3603a825e03a545ce34d9bc82ab26a5d8ca197079b655de38d74202","signature":"0x3b1a01db18ec27fcae50f109b84e83f7034afd0a854927571c9f4c1f1b54c70b0b820006c9bc86b2a64d937a8bb9dd3ab5627bddfe4e516f256a0be16d7040021c"}}}